The federal cabinet has taken a significant step towards ensuring public health safety by approving the nationwide implementation of a Track and Trace System for pharmaceutical products. This move is aimed at strengthening medicine safety and eliminating counterfeit drugs from the market, which have been a major concern for the country's healthcare system.
The Track and Trace System is designed to provide a robust mechanism for monitoring and tracking pharmaceutical products throughout their supply chain, from manufacturing to distribution and finally to the end consumer. This system will enable regulatory authorities to keep a close eye on the movement of medicines, detecting and preventing the entry of counterfeit products into the market.
The implementation of the Track and Trace System is expected to have a significant impact on the pharmaceutical industry in Pakistan. It will not only help to protect the public from the dangers of counterfeit medicines but also promote a culture of transparency and accountability among pharmaceutical manufacturers and distributors. By ensuring that all pharmaceutical products are genuine and safe for consumption, the system will help to build trust between the public and the pharmaceutical industry.
The approval of the Track and Trace System is a major milestone in the government's efforts to regulate the pharmaceutical industry and ensure that the public has access to safe and effective medicines. The system will be implemented in phases, with the first phase focusing on the tracking and tracing of high-risk pharmaceutical products. As the system is rolled out nationwide, it is expected to have a significant impact on the reduction of counterfeit medicines in the market, ultimately leading to improved public health outcomes.
